When Nothing Else Has Worked, Ketamine Therapy Is Worth Understanding
You've probably already tried the standard path — antidepressants, therapy, maybe both at once. And if you're here, there's a good chance that path hasn't gotten you where you need to be.
Ketamine therapy has become one of the most significant developments in mental health treatment in decades. Not because it's new, but because clinicians now understand how to use it for people who've exhausted conventional options. It's FDA-recognized, clinically studied, and increasingly available through specialized practices equipped to administer it safely.
This guide covers what ketamine therapy actually is, how it works in the brain, what conditions it treats, and what receiving it looks like in practice. If you're exploring this for yourself or someone you care about, this is where to start.
What Is Ketamine?
Ketamine was first synthesized in the 1960s and FDA-approved in 1970 as an anesthetic. It's been used in surgical settings, emergency medicine, and battlefield trauma care for more than fifty years. At appropriate doses, its safety profile is well established.
What shifted in recent decades is our understanding of what ketamine does to the brain beyond anesthesia. Researchers began noticing that patients receiving ketamine in clinical settings reported rapid — sometimes dramatic — improvements in mood, even those with severe, long-standing depression. That observation sparked a wave of research that has since produced compelling evidence for ketamine as a psychiatric treatment.
Today, ketamine is used in two primary forms for mental health care:
- IV ketamine infusion therapy — delivered intravenously at a sub-anesthetic dose in a clinical setting, allowing precise control over dosage and delivery
- Spravato® (esketamine) — a nasal spray form of esketamine, a close chemical relative of ketamine, that received FDA approval in 2019 specifically for treatment-resistant depression and major depressive disorder with suicidal ideation
Both are used in supervised medical settings. Neither is a take-home prescription. That clinical oversight is a core part of what makes them safe and effective.
How Does Ketamine Therapy Work?
This is where ketamine gets genuinely interesting — and where it parts ways with every antidepressant you've likely tried.
The Problem With Traditional Antidepressants
Most antidepressants — SSRIs, SNRIs, MAOIs — work by targeting the serotonin or norepinephrine systems, adjusting how those neurotransmitters are absorbed and reused. That mechanism can work, but it has a real limitation: it's slow. Antidepressants typically take four to six weeks to produce meaningful effects, if they work at all. For roughly 30% of people with major depression, they don't produce adequate relief even after multiple medication trials.
Ketamine’s Mechanism: Glutamate and Neuroplasticity
Ketamine works on an entirely different system. It acts primarily as an NMDA receptor antagonist — blocking a specific receptor in the brain that responds to glutamate, the brain's most abundant excitatory neurotransmitter.
When ketamine blocks NMDA receptors, a cascade follows. The brain releases a surge of glutamate, which activates a different set of receptors called AMPA receptors. This triggers the release of BDNF — brain-derived neurotrophic factor — a protein central to neuroplasticity, the brain's ability to form new connections and reorganize itself.
In plain terms: ketamine appears to help the brain physically rewire.
For people living with depression, anxiety, PTSD, or chronic pain, years of illness can cause measurable structural changes in the brain — particularly in areas like the prefrontal cortex and hippocampus, which regulate mood, decision-making, and memory. Ketamine's ability to rapidly stimulate neuroplasticity may help restore some of that lost function.
Why the Speed Matters
One of ketamine's most clinically significant qualities is how quickly it acts. Many patients report noticeable improvement within hours of their first infusion. For someone in the depths of severe depression or struggling with active suicidal ideation, that speed isn't just convenient — it can be life-saving.
Traditional antidepressants can't do this. The weeks-long delay isn't a minor inconvenience for people in crisis; it's a meaningful gap in care. Ketamine fills that gap in a way no other widely available treatment currently can.
What Conditions Does Ketamine Therapy Treat?
Ketamine therapy isn't a general wellness treatment. It's a targeted clinical intervention for specific, often serious conditions — particularly those that haven't responded adequately to conventional care.
Treatment-Resistant Depression
This is the most well-documented use case. Treatment-resistant depression (TRD) is generally defined as depression that hasn't responded to at least two adequate antidepressant trials. It's more common than most people realize, and it carries serious risk — including elevated suicide risk.
Multiple clinical studies and real-world data have shown that ketamine produces rapid antidepressant effects in a meaningful percentage of TRD patients. It doesn't work for everyone, but the response rates are strong enough that ketamine is now considered a legitimate, evidence-based option within psychiatric care.
PTSD
PTSD involves deeply ingrained fear memories and hyperactivated stress responses that are notoriously hard to treat. Ketamine's effect on neuroplasticity may help disrupt entrenched trauma pathways, making it easier for the brain to process and integrate difficult experiences.
At Valor Health Solutions, PTSD treatment is a core focus — in part because the practice was founded by veterans and mental health professionals who understand firsthand how often conventional PTSD treatment falls short for those who have served.
Anxiety Disorders
Severe anxiety, including generalized anxiety disorder and social anxiety, has also been studied in the context of ketamine therapy. The evidence base here is somewhat smaller than for depression, but clinical experience and emerging research suggest meaningful relief is possible for patients whose anxiety hasn't responded to standard treatments.
Chronic Pain
Ketamine has a longer history in pain medicine than in psychiatry. At sub-anesthetic doses, it can reduce central sensitization — a process where the nervous system becomes chronically overactivated and amplifies pain signals. Conditions like complex regional pain syndrome (CRPS), fibromyalgia, and neuropathic pain are among those where ketamine infusions have shown documented benefit.
Major Depressive Disorder With Suicidal Ideation
Spravato® received specific FDA approval for major depressive disorder with acute suicidal ideation or behavior — a high-stakes indication that reflects how seriously the clinical community takes ketamine's rapid-acting properties in crisis situations.
What Does Ketamine Therapy Actually Look Like?
Understanding the mechanism is one thing. Knowing what you're actually signing up for is another.
The Initial Evaluation
Responsible ketamine therapy starts with a thorough clinical assessment — not a rubber-stamp process. A qualified provider will review your psychiatric and medical history, current medications, prior treatment attempts, and overall health. Not everyone is a candidate. Certain medical conditions, substance use histories, or medication interactions may make ketamine therapy inadvisable.
At Valor Health Solutions, this evaluation is built into the process from the beginning. The goal is to determine whether ketamine therapy is genuinely the right fit — not simply to fill a treatment slot.
IV Ketamine Infusion: What to Expect
For IV infusions, you'll typically sit in a reclined chair or lie on a treatment table in a calm, monitored clinical environment. An IV line is placed, and the infusion runs over approximately 40 to 60 minutes at a carefully calibrated sub-anesthetic dose.
During the infusion, most patients experience a dissociative state — a sense of detachment from ordinary perception. This can include altered visual or auditory experiences, a dreamlike quality, or a feeling of floating. For some patients, it's mildly disorienting. For others, it's described as peaceful or even profound.
Clinical staff monitor you throughout. Vital signs are tracked. You're not unconscious — most patients can speak and respond, though many prefer to close their eyes and rest.
The dissociative effects typically fade within 30 to 60 minutes after the infusion ends. You'll need someone to drive you home, and most providers recommend avoiding demanding tasks or major decisions for the rest of the day.
Spravato® (Esketamine): What to Expect
Spravato is administered as a nasal spray in a certified healthcare setting. You self-administer the spray under clinical supervision, then remain in the office for a two-hour observation period. Like IV ketamine, it can produce dissociative effects during that window.
Spravato is typically used alongside an oral antidepressant, as required by the FDA approval. The standard schedule is twice weekly for the first month, then weekly, then every one to two weeks as a maintenance dose.
How Many Sessions Are Needed?
This varies by person and condition. A standard initial course of IV ketamine infusions for depression is often six sessions over two to three weeks. Some patients respond after two or three; others need the full course. Maintenance infusions — monthly or as needed — are common for sustaining benefit over time.
Spravato follows a more structured dosing schedule defined by the FDA approval protocol. Your provider will work with you to determine the right approach based on your response and clinical picture.
The Role of Psychotherapy
Ketamine therapy works best when integrated with psychotherapy. The neuroplasticity ketamine stimulates creates a window of enhanced psychological flexibility — a period when the brain may be more receptive to new patterns of thinking and emotional processing.
Some providers offer ketamine-assisted psychotherapy (KAP), where therapeutic work happens during or immediately after the infusion. Others structure therapy sessions around the infusion schedule. Either way, treating ketamine as a standalone intervention rather than part of a broader care plan is generally a missed opportunity.
Is Ketamine Therapy Safe?
Safety is a reasonable concern. Here's what the evidence and clinical experience actually show.
Known Side Effects
At the sub-anesthetic doses used in therapeutic settings, ketamine's side effects are generally manageable and temporary. Common ones include:
- Dissociation or perceptual changes during the session
- Nausea (often managed with pre-treatment medication)
- Dizziness or lightheadedness
- Elevated blood pressure during infusion
- Fatigue afterward
Serious adverse events are rare when ketamine is administered by trained clinicians in appropriate settings. This is not a treatment to seek outside of a legitimate medical practice.
Abuse Potential
Ketamine has a history of recreational misuse, and that's worth acknowledging honestly. At the doses and frequencies used therapeutically, the risk of dependence is considered low — but it isn't zero. Reputable providers screen patients carefully and monitor for any signs of problematic use.
This is one reason ketamine therapy is always administered in a clinical setting rather than prescribed for home use — with the partial exception of Spravato, which is self-administered under observation in a certified provider's office.
Who Should Not Pursue Ketamine Therapy
Ketamine isn't appropriate for everyone. Contraindications include:
- Uncontrolled hypertension
- Active or history of psychosis or schizophrenia
- Certain cardiovascular conditions
- Active substance use disorders, particularly involving stimulants or dissociatives
- Some medication interactions
A thorough intake evaluation matters precisely because these factors are real. Any provider willing to skip that step isn't one you should trust.
Ketamine Therapy at Valor Health Solutions
Valor Health Solutions offers both IV ketamine infusion therapy and Spravato® at locations in Clearwater, Florida and Johnson City, Tennessee, with virtual services available for appropriate care needs.
The practice was founded by veterans and mental health professionals — people who have seen firsthand how treatment-resistant conditions can devastate lives, and how often the conventional system fails people who need more than a prescription and a referral.
That background shapes how care is delivered here. The focus is on evidence-based treatment, honest clinical evaluation, and integrated care that addresses the whole person — not just the presenting symptom.
Ketamine therapy isn't right for everyone. But for people who have tried what's available and still aren't where they need to be, it's a serious option backed by serious science.
A Different Kind of Treatment for a Different Kind of Need
Ketamine therapy works differently than anything that came before it. It targets a different brain system, acts on a different timeline, and serves a different population — people for whom conventional treatment hasn't been enough.
That doesn't make it a cure-all. It doesn't work for everyone, and it works best as part of a broader plan that includes therapy and ongoing support. But the evidence is real, the mechanism is understood, and the clinical experience of thousands of patients points in a consistent direction: for the right person, ketamine therapy can produce meaningful, sometimes life-changing relief.
If you're exploring this for yourself or someone you care about, the next step is a conversation with a qualified provider who can honestly assess whether it's the right fit.
Learn more at valorhealthconnect.com.
